DEFA14A: Gossamer Bio Seeks Shareholder Approval for Auditor Ratification at Upcoming Annual Meeting
Proxy Statement
Gossamer Bio is holding its annual meeting and seeking shareholder ratification of Ernst & Young LLP as its independent auditor for the year ending December 31, 2020.
Summary
- Gossamer Bio is holding an annual meeting.
- Shareholders are being asked to ratify the appointment of Ernst & Young LLP as the company's independent registered public accountants for the year ending December 31, 2020.
- The meeting will provide virtual attendance options via www.proxydocs.com/GOSS.
- Shareholders can register for the virtual meeting using the control number provided.
- Shareholders can vote via internet at www.investorelections.com/GOSS, telephone at (866) 648-8133, or email at paper@investorelections.com.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, indicating a neutral sentiment.
Positives
- The company is providing multiple options for shareholders to vote, including internet, telephone, and email.
Industry Context
Ratification of auditors is a standard corporate governance practice.
Stakeholder Impact
- Shareholders will have the opportunity to vote on the ratification of the company's auditor.
- The outcome of the vote will impact the company's corporate governance.
Next Steps
- Shareholders will vote on the ratification of the auditor.
- The company will hold its annual meeting.
Key Dates
| Date | Description |
|---|---|
| December 31, 2020 | Year ending for which Ernst & Young LLP is proposed as the independent registered public accountants. |
Keywords
Gossamer Bio, Annual Meeting, Proxy Statement, Ernst & Young, Auditor Ratification, Shareholders
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.